https://www.optometrytimes.com/view/arvo-2026-miyosmart-iq-demonstrates-myopia-control-in-children-as-young-as-aged-4 A new clinical trial presented at ARVO 2026 by HOYA Vision Care and The Hong Kong Polytechnic University is turning heads in myopia management. The randomized controlled trial enrolled 196 school children in Hong Kong, ages 4 to 12, and the results were striking: the new spectacle lens design halted clinically relevant myopia progression […]
Continue Reading... No Comments.